Design and main results:
🚩MDT vs ENRT, both arms 6mo of ADT
🚩Higher GU2+ tox in ENRT arm, but mainly due to more prostate bed RT in this arm
🚩Omitting PB RT results in higher rate of local failures
🚩Locoregional control superior with ENRT: 90% control @ 3yr.
🏴MFS not mature

Hi M. Bolton, I refer you to bullet points 3 and 4 on the slide you posted below. Hope
we can meet sometime and discuss this in person.

Too many concurrent talks from Team The Royal Marsden NHS Foundation Trust The ICR !! Sad to miss this one! MR-Linac Consortium

#ESTRO24 Piet Ost presenting outcomes of STORM randomized Ph II of MDT v ENRT for oligorecurrent prostate cancer #pcsm

✅ ENRT ⬆️BRFS, LRFS

MDT a/w 8-fold ⬆️ nodal recurrence 3➡️25%

Omitting PB ⬆️ local recurrences 3-fold (5➡️14%), but also increases GU2+ toxicity

Lovely work from Himanshu Nagar, five fraction prostate bed MRIg SBRT is looking very promising. Can’t wait to see the two year results! #ESTRO24

Today, at #ESTRO24 , the @MR_linac Consortium is extending a warm welcome to the #MRgRT community! We kick off with an great overview by anna bruynzeel showcasing compelling evidence that MRgRT is improving outcomes for pancreas, kidney and prostate radiotherapy on Unity and MRIdian

Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance–Guided Radiotherapy | Oncology | JAMA Network Open | JAMA Network jamanetwork.com/journals/jaman…

The MR Linac team The Royal Marsden NHS Foundation Trust had an exciting week by completing on-site training with Elekta to  learn about Comprehensive Motion Management.
We look forward to using CMM  to enhance radiotherapy delivery

Alison Tree 💙🇺🇦 Trina (Tree) Herbert 💙 Sophie Alexander 💙 Robert Huddart💙

Outside of de novo high volume metastatic #ProstateCancer situation, #APCCC24 voting results on who could/should get a triplet…

Our editorial in European Urology on prostate radiotherapy for mHSPC is now online ! Chris Parker

Read here:
authors.elsevier.com/c/1i~y6_6tuN-i…

RM_Radiotherapy The Royal Marsden NHS Foundation Trust The ICR #prostatecancer

📢 Calling all breast cancer clinicians in the UK and Internationally! Please participate in our survey on the use of SBRT in oligometastatic breast cancer. Your insights will help shape future clinical trial design!💫

Anna Kirby
#BreastCancer #SBRT
 
forms.office.com/e/DVp7uQYrPj

Today, The Royal Marsden launched its Five-Year Clinical Strategy, in partnership with The ICR.

For more information about new strategy, and to see our achievements from the past five years, visit: bit.ly/4aVCAno

This was very educational and also fun last year, do consider registering!

Happy to share our work describing patterns of nodal recs (PSMA) after prostate-only RT in HRCaP.
✓ Pelvic caudal border definition varies - RTOG v PIVOTAL v NRG v GFRU!
Vedang Murthy Priyamvada Maitre Rishika Mody TMC Radiation Oncology Clinical Oncology

ENZA-p trial The Lancet Oncology
authors.elsevier.com/a/1iw3e5EIIgPd…
Enzalutamide + adaptive-dosed (2 or 4) 177 Lu-PSMA617 vs enza alone in mCRPC.
Biomarker guided combination therapy works!
Better response depth/duration with no added tox. ANZUP NHMRC CTC Movember Australia St Vincent's Sydney

FREE Early Bird Registration to this year's MR-Linac Consortium Meeting 13th - 15th November in Singapore! Our colleagues at Siriraj Hospital and Mahidol University are excited to see you there! #MRgRT

Very excited to announce the official publication of the SABR Dual protocol - 2 fx vs 5 fx SABR for localized prostate ca. Phase 1 cohort completed, now randomizing. Allows for CT or MR-Linac, requires a hydrogel spacer link.springer.com/article/10.118…

Absolutely brilliant writing, beautifully encapsulating the challenges and opportunities of our field and the need for Common Sense Oncology across disciplines. Great work Dr. Nina Niu Sanford Dr. Fabio Moraes Ajay Aggarwal Laura Dawson
Bishal Gyawali and team thegreenjournal.com/article/S0167-…